Sign in
Taking peopleNo phase

Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score

Key facts

Who runs it
Azienda Ospedaliero-Universitaria Careggi
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
13 Nov 2025
Expected to end
13 Nov 2031
Type of study
Observational, 2 groups
Treatments tested
  • FUNGAL-P Score Assessment
Record updated
2 July 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age ≥18 years and ≤90 years
  • Presentation to the Emergency Department or hospital with pneumonia
  • Pneumonia defined according to IDSA/ATS criteria as the presence of at least two clinical signs or symptoms of lower respiratory tract infection (temperature <36.0°C or >38.0°C, respiratory rate >20 breaths/min, oxygen saturation <90% on room air, arterial PaO₂ <60 mmHg, cough, sputum production, white blood cell count <4,000/μL or >10,000/μL, or bandemia >10%) together with radiographic evidence of a new pulmonary infiltrate or cavitary lesion
  • Bronchoalveolar lavage (BAL), bronchial aspirate (BAS), or endotracheal aspirate (ETA) performed within 48 hours of hospital presentation
  • Modified Rankin Scale score <5
  • Availability of microbiological investigations for identification of fungal, bacterial, or viral pathogens
  • Provision of informed consent, when required by applicable regulations and ethics committee approval

Who cannot take part

  • Age <18 years or >90 years
  • Refusal or withdrawal of informed consent
  • Pregnancy
  • Expected life expectancy <3 months
  • Hospital-acquired pneumonia with onset >48 hours after hospital admission
  • Modified Rankin Scale score ≥5
  • Absence of microbiological diagnostic evaluation
  • No identified bacterial, fungal, or viral pathogen after microbiological investigations

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The FUNGAL-P study is a single-center observational study designed to derive and validate a clinical prediction score for the early identification of fungal pneumonia in adult patients presenting with pneumonia.

Read full original descriptionShow less

The study includes a retrospective derivation cohort and a prospective validation cohort of patients undergoing microbiological evaluation of lower respiratory tract samples. Clinical, laboratory, radiological, microbiological, and treatment-related variables associated with fungal pneumonia will be analyzed to identify independent predictors of fungal infection. These predictors will be combined to develop the FUNGAL-P score.

The derived score will subsequently be evaluated in a prospective validation cohort to assess its diagnostic performance, calibration, and clinical utility. The ultimate goal is to facilitate earlier recognition of fungal pneumonia and support timely diagnostic testing and antifungal treatment in patients presenting to the Emergency Department or hospital with pneumonia.

The 2 groups in the trial

  • Retrospective Derivation Cohort

    Adult patients with microbiologically confirmed pneumonia enrolled at Careggi University Hospital between January 1, 2022 and December 31, 2023. Clinical, laboratory, radiological, microbiological, treatment, and outcome data were collected to identify independent predictors of fungal pneumonia and to derive the FUNGAL-P clinical prediction score.

    Treatment: FUNGAL-P Score Assessment

  • Prospective Validation Cohort

    Consecutive adult patients with pneumonia enrolled at Careggi University Hospital between 13 nov, 2025 and December 31, 2030. The cohort was used to prospectively evaluate the diagnostic performance, calibration, and clinical utility of the derived FUNGAL-P score without influencing clinical management.

    Treatment: FUNGAL-P Score Assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07681583, who can take part
Record updated
2 July 2026